Moderna Inc said the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunisation Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.
The panel voted 11-0 in favour of the vaccine, the company said in a press release.
The vote result came a day after the Food and Drug Administration's authorisation for emergency use of Moderna's COVID-19 vaccine.
"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.
Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc and German partner BioNTech SE got the green light for emergency use.
US distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.
US, India agree on trade deal and lower tariffs, says Trump
Israel reopens Gaza's Rafah border crossing to Egypt, with limits
US envoy Witkoff to visit Israel, meet Netanyahu, Israeli officials say
Russian drone strike kills 12 miners in Ukraine
Singapore to launch space agency in response to global investment surge
Five-year-old boy returns to Minnesota after ICE release
Reopening of Gaza's Rafah crossing expected Monday
Winter storm death toll in United States reaches 90
